GSK PLC (LSE:GSK)
£ 13.97 0.16 (1.16%) Market Cap: 57.00 Bil Enterprise Value: 69.85 Bil PE Ratio: 22.90 PB Ratio: 4.07 GF Score: 69/100

GlaxoSmithKline PLC at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript

Sep 17, 2020 / 07:15AM GMT
Release Date Price: £15.32 (+0.76%)
Unidentified Participant

This presentation is for Bank of America clients only. If you are a member of the media or the press, please disconnect now.

Graham Glyn Charles Parry
BofA Merrill Lynch, Research Division - MD and Head of Healthcare Equity Research

Okay. Good morning, everybody, and welcome to day 2 of the Bank of America Global Healthcare Conference. For those of you who don't know me, I'm Graham Parry, one of the European pharma analysts here at Bank of America. And I'm very pleased today to be able to introduce our first company and, in particular, Emma Walmsley, the CEO of GlaxoSmithKline.

As with the session yesterday, if you have any questions, then please enter them directly into the Veracast website and I'll ask them. Alternatively, if you're having any technical difficulties with that, then you can also e-mail them through to me at [email protected].

So Emma, welcome to the conference. Shame we couldn't see you in person, but I think this is the closest that we can get. And perhaps I'll just kick off the -- our fireside chat

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot